Z-0753-2024 Class II Ongoing

Recalled by Randox Laboratories Ltd. — Crumlin (North), N/A

FDA device recall Z-0753-2024 was initiated by Randox Laboratories Ltd. on Nov 20, 2023 and is designated Class II. Reason for recall: Target for Alkaline Phosphatase (ALP) for the AMP optimized to IFCC 37¿C method has been mis-assigned for the RX Series instruments by approximately 10% on Quality Control and patient samples The recall status is ongoing. Affected quantity: 108 kits.

Recall details

Product Type
Devices
Report Date
Jan 24, 2024
Initiation Date
Nov 20, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
108 kits

Product description

Calibration Serum Level 3 - IVD For use as a Calibrator in clinical chemistry assays Catalog Number: CAL2351

Reason for recall

Target for Alkaline Phosphatase (ALP) for the AMP optimized to IFCC 37¿C method has been mis-assigned for the RX Series instruments by approximately 10% on Quality Control and patient samples

Distribution pattern

US Nationwide including Puerto Rico.

Code information

GTIN: 05055273200966 Lot/Batch No: 1214UE Exp. Date: 28 Nov 2023

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0753-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0753-2024. Report a data issue: hello@regdatalab.com.